Tomorrow’s Breakthroughs Today: Immunotherapy and the Cancer Research Institute

Leading scientists discuss the role that the Cancer Research Institute (CRI) has played in advancing the science of cancer immunotherapy. For more than 60 years, CRI has been at the forefront of this revolutionary treatment approach, which mobilizes the body's immune system to attack and eliminate cancer. Featured scientists include: Alex Huang, M.D., Ph.D., Associate Professor, Case Western Reserve School of Medicine; Juan R. Cubillos-Ruiz, Ph.D., Weill Cornell Medical College; Ryan Teague, Ph.D., Assistant Professor, Saint Louis University School of Medicine; Nicholas P. Restifo, M.D., Senior Investigator, National Cancer Institute; and Margaret K. Callahan, M.D., Ph.D., Memorial Sloan Kettering Cancer Center